Zhiguang Fu

672 total citations
17 papers, 571 citations indexed

About

Zhiguang Fu is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Zhiguang Fu has authored 17 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Immunology and 4 papers in Oncology. Recurrent topics in Zhiguang Fu's work include Signaling Pathways in Disease (6 papers), Galectins and Cancer Biology (6 papers) and Cancer Cells and Metastasis (2 papers). Zhiguang Fu is often cited by papers focused on Signaling Pathways in Disease (6 papers), Galectins and Cancer Biology (6 papers) and Cancer Cells and Metastasis (2 papers). Zhiguang Fu collaborates with scholars based in China and United States. Zhiguang Fu's co-authors include Zhi‐Nan Chen, Jian‐Li Jiang, Bo Wu, Jing Lin, Zhenyu Liu, Jianghua Li, Ning Wen, Lisheng Zhao, Juan Xu and Peng Yin and has published in prestigious journals such as Scientific Reports, Small and Cancer Letters.

In The Last Decade

Zhiguang Fu

17 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhiguang Fu China	11	419	145	119	97	64	17	571
Ankai Xu China	11	219 0.5×	172 1.2×	104 0.9×	101 1.0×	78 1.2×	14	545
Yoram Faitelson Israel	6	307 0.7×	90 0.6×	79 0.7×	144 1.5×	47 0.7×	12	634
Yunzhen Gao China	12	206 0.5×	107 0.7×	91 0.8×	68 0.7×	91 1.4×	18	436
Xinhan Zhao China	14	427 1.0×	121 0.8×	204 1.7×	191 2.0×	39 0.6×	44	684
Zhumei Cui China	19	420 1.0×	152 1.0×	208 1.7×	150 1.5×	56 0.9×	43	739
Chao Zeng China	11	244 0.6×	89 0.6×	199 1.7×	92 0.9×	67 1.0×	23	466
Ning Kang China	8	203 0.5×	294 2.0×	151 1.3×	110 1.1×	71 1.1×	11	566
Leiming Guo China	15	266 0.6×	100 0.7×	93 0.8×	158 1.6×	43 0.7×	30	511
Jiansen Lu China	9	335 0.8×	158 1.1×	83 0.7×	122 1.3×	62 1.0×	19	742
Huo Tan China	13	216 0.5×	122 0.8×	131 1.1×	115 1.2×	43 0.7×	43	472

Countries citing papers authored by Zhiguang Fu

Since Specialization

Citations

This map shows the geographic impact of Zhiguang Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiguang Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiguang Fu more than expected).

Fields of papers citing papers by Zhiguang Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiguang Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiguang Fu. The network helps show where Zhiguang Fu may publish in the future.

Co-authorship network of co-authors of Zhiguang Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiguang Fu. A scholar is included among the top collaborators of Zhiguang Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiguang Fu. Zhiguang Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Gao, Jian, et al.. (2025). Antibody-functionalized iron-based nanoplatform for ferroptosis-augmented targeted therapy of HER2-positive breast cancer. Bioactive Materials. 52. 702–718. 2 indexed citations

Luo, Yu, Kexin Zhang, Rui Zhang, et al.. (2025). Cascade‐amplified Oxidative Stress via Bandgap‐Tuned KBiO ₃ Perovskite for Cancer Therapy. Small. 21(26). e2501860–e2501860. 3 indexed citations

Liu, Lihua, et al.. (2022). Comparison of involved-field intensity-modulated radiotherapy combined with S-1 vs radiotherapy alone for elderly patients with esophageal cancer. World Journal of Clinical Cases. 10(21). 7365–7375. 1 indexed citations

Fu, Zhiguang, Yizhu Wang, Yaping Sun, et al.. (2020). Correlation of carbonic anhydrase 9 (CA9) with pathological T-stage and prognosis in patients with oral tongue squamous cell carcinoma. Annals of Translational Medicine. 8(22). 1521–1521. 8 indexed citations

Yang, Shuo, Biao Zhu, Peng Yin, et al.. (2020). Integration of Human Umbilical Cord Mesenchymal Stem Cells-Derived Exosomes with Hydroxyapatite-Embedded Hyaluronic Acid-Alginate Hydrogel for Bone Regeneration. ACS Biomaterials Science & Engineering. 6(3). 1590–1602. 136 indexed citations

Li, Tian, et al.. (2019). Triptolide reduces proliferation and enhances apoptosis in drug-resistant human oral cancer cells.. PubMed. 12(4). 1204–1213. 3 indexed citations

Li, Yunxia, Wenjuan Du, Zhiguang Fu, et al.. (2018). pH-Responsive Polycarbonate Copolymer-based Nanoparticles for Targeted Anticancer Drug Delivery. Chemical Research in Chinese Universities. 34(6). 1041–1050. 5 indexed citations

Lin, Jing, Fei Song, Zhenyu Liu, et al.. (2017). MLKL-PITPα signaling-mediated necroptosis contributes to cisplatin-triggered cell death in lung cancer A549 cells. Cancer Letters. 414. 136–146. 45 indexed citations

Fu, Zhiguang, Xiaoqing Wu, Bo Wu, et al.. (2016). Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling. Oncotarget. 7(38). 62177–62193. 23 indexed citations

10.

Li, Jianghua, Wan Huang, Lin Peng, et al.. (2016). N-linked glycosylation at Asn152 on CD147 affects protein folding and stability: promoting tumour metastasis in hepatocellular carcinoma. Scientific Reports. 6(1). 35210–35210. 36 indexed citations

11.

Fu, Zhiguang, Li Wang, Hong‐Yong Cui, et al.. (2016). A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells. Oncotarget. 7(8). 9429–9447. 56 indexed citations

12.

Fu, Zhiguang, et al.. (2015). Cytoplasmic EpCAM over-expression is associated with favorable clinical outcomes in pancreatic cancer patients with Hepatitis B virus negative infection.. PubMed. 8(12). 22204–16. 13 indexed citations

13.

Cui, Hong‐Yong, Shijie Wang, Jiyu Miao, et al.. (2015). CD147 regulates cancer migrationviadirect interaction with Annexin A2 and DOCK3-β-catenin-WAVE2 signaling. Oncotarget. 7(5). 5613–5629. 30 indexed citations

14.

Liu, Zhenyu, Bo Wu, Yunshan Guo, et al.. (2015). Necrostatin-1 reduces intestinal inflammation and colitis-associated tumorigenesis in mice.. PubMed. 5(10). 3174–85. 94 indexed citations

15.

Geng, Jiejie, Kui Zhang, Lina Chen, et al.. (2014). Enhancement of CD147 on M1 macrophages induces differentiation of Th17 cells in the lung interstitial fibrosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(9). 1770–1782. 16 indexed citations

16.

Wang, Shijie, Hong‐Yong Cui, Yanmei Liu, et al.. (2014). CD147 promotes Src-dependent activation of Rac1 signaling through STAT3/DOCK8 during the motility of hepatocellular carcinoma cells. Oncotarget. 6(1). 243–257. 40 indexed citations

17.

Song, Nan, Yanping Ding, Wei Zhuo, et al.. (2012). The nuclear translocation of endostatin is mediated by its receptor nucleolin in endothelial cells. Angiogenesis. 15(4). 697–711. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact